Miromatrix Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Miromatrix Medical generated cash of -$26,682,581, which is less than the previous year. Cash used in financing activities reached the amount of $168,337 last year. Net change in cash is therefore -$47,603,526.
Cash Flow
| 2019 | -8.32M | 10.36M | 312.34K |
|---|---|---|---|
| 2020 | -8.03M | 2.87M | 6.35M |
| 2021 | -14.80M | -1.38M | 65.35M |
| 2022 | -26.68M | -21.08M | 168.33K |
MIRO Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 53.61M | 4.44M | 3.25M | 901.23K |
Operating activities | ||||
Net income | -29.95M | -14.67M | -10.30M | -4.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 1.10M | 167.90K | 170.36K | 344.13K |
Stock-based compensation expense | 1.15M | 622.15K | 644.85K | 918.48K |
| Deferred income tax benefit | 1.15M | 622.15K | 644.85K | 918.48K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 42.17K | 169.45K |
Inventories | 0 | 0 | 0 | 121.34K |
Accounts payable | 500.62K | 1.06M | -467.60K | -124.56K |
Cash generated by operating activities | -26.68M | -14.80M | -8.03M | -8.32M |
Investing activities | ||||
Purchases Of Investments | -26.02M | -2B | 0 | -10.46M |
Investments In Property Plant And Equipment | -1.06M | -3.38M | -123.16K | -101.45K |
Acquisitions Net | 20.02M | 2M | 3M | 2.49M |
Cash generated by investing activities | -21.08M | -1.38M | 2.87M | 10.36M |
Financing activities | ||||
Common Stock Issued | 0 | 44.52M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | -3.35K | 0 | 0 | 0 |
Repayments of term debt | 0 | -122.77K | -271.99K | 0 |
Cash used in financing activities | 168.33K | 65.35M | 6.35M | 312.34K |
Net Change In Cash | -47.60M | 49.16M | 1.19M | 2.34M |
Cash at end of period | 6.00M | 53.61M | 4.44M | 3.25M |
| Data source | Data source |